2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...
LIG³Ø½º¿ø-Áß¾ÓÀüÆÄ°ü¸®¼Ò, ¹æÀ§»ê¾÷ ¼ºÀå MOU (2024-08-14)
°¨Åº°è ½¡ºÒġŲ, ´Ü§À¸·Î MZ Àú°Ý (2024-01-10)
¡®³» ±Í¿¡ ¶ò°î¡¯ ¸®ÇìÀÌ, ÀÌÈ¿¸® ¼º´öµÈ »ç¿¬ °í¹é (2023-12-09)
¡®ÇÑ ¹øÂë ÀÌÈ¥ÇÒ °á½É¡¯ 20¾ï »ç±â ´çÇÑ ÃÖÁؼ® (2024-08-25)
From Brain-Computer Chips to Climate Change: Dubai Future Fo... (2024-12-04)
AI Ȱ¿ë ÀÚÀ²ÁÖÇà·Îº¿ ÅëÇÕ Á¦¾î Ç÷§Æû °³¹ß (2024-07-26)
ÆÛ½Ã½º ´ë±¸¼¾ÅÍ ¼î·ë¡¤ÀÏ·ë ´ë±¸ ÇÁ¸®¹Ì¾ö¼¥ ¿ÀÇ (2017-04-24)
»ç¿ì½ºÄÉÀÌÇÁ, JTBC GOLF ¡®½Ã±×´Ïó ¶ó¿îµå¡¯ Á¦ÀÛÁö¿ø (2024-05-25)
°íµîµ¿¡¤¸Å»êµ¿ Ãë¾à°èÃþ À§ÇÑ »ç¶ûÀÇ ¹ÝÂù ³ª´® (2024-08-06)
³õÄ£ º¸Çè±Ý ã¾ÆÁÖ´Â ¶óÀÌÇÁijġ (2022-11-12)
Çö´ëÂ÷•±â¾Æ, ñé Ä¿³ØÆ¼µåÄ« »ýŰè Á¶¼º ³ª¼±´Ù (2024-05-04)
³²¼º ¾Ö½½·¹Àú ÀÇ·ù ÆÇ¸Å·® 68.8% Áõ°¡ (2024-01-20)
IBK½Å¿ëÁ¤º¸, Áß¼Ò±â¾÷Áß¾Óȸ¿Í ¹Ì¼öä±Ç °ü¸®¾÷¹« Çù¾à (2024-08-30)
¼ÓÃÊÀÇ ¿À·¡µÈ Á¶¼±¼Ò¿¡¼­ ¹Ì¼úÀÛǰ ÆË´Ï´Ù (2024-06-14)
Á¦³ªÀ£´Ï½º, û³â µðÀÚÀÌ³Ê ÆíÁý¼ó ¡®ÅÙ¹ÙÀ̺ꡯ »ç¾÷¼³¸íȸ (2024-07-14)
ÀÏ»ó ¼Ó ÀÛÀº ÀεµÁÖÀÇ ½ÇõÇϱâ Ä·ÆäÀÎ (2020-08-18)
¿¹½º24, Å©·¹¸¶Å¬·´ 7¿ù ȸ¿ø°¡ÀÔ À̺¥Æ® (2024-07-08)
PUMA Opens New Creative Hub Studio48 to Foster Excellence in... (2024-12-22)
Women's Health Remains in Crisis Worldwide Even as COVID-19 ... (2024-01-21)
SK, 1000¾ï´ë ±â¾÷°¡Ä¡ ¡®ÀÓÆÑÆ® À¯´ÏÄÜ¡¯ 2°³³ª Ű¿ü´Ù (2023-11-20)
PCI Pharma Services Invests Over $365 Million in EU, US Faci... (2024-10-06)
Lineage Acquires Warehousing and e-Commerce Assets of Burris... (2023-10-04)
·Î¶Ç ´ç÷ÀÇ À̷аú ½ÇÁ¦ (2023-06-30)
ÇÁ¸®¹Ì¾ö È­Àåǰ ½ÃÀå °ø·« º¸´Ð½º ·ÐĪ ¼¼¹Ì³ª (2023-08-29)
¾ÆÀÏ·£µå ÇÁ¸®¹Ì¾ö ¾×»ó ¿µ¾çÁ¦ ¡®µµ±â·¹À̵塯 ±¹³» Ãâ½Ã (2023-10-13)
       [ÀÌÀü][1]....[556][557][558][559][560][561][562][563][564]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..